Do you want to understand how AI is already changing medicine? Novo Nordisk is using AI agents to accelerate its GLP-1 drug pipeline, shaving *weeks to months* off clinical trials, potentially worth hundreds of millions in faster time-to-market. The Ozempic maker uses agents

→ View original post on X — @kimmonismus